Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Physiomics provides advanced mathematical modeling, simulation, biostatistics, and data science services to pharmaceutical and biotech companies. Their proprietary Virtual Tumour™ technology enables prediction of cancer drug effects in silico to optimize R&D decisions. They have supported over one hundred projects across more than one hundred twenty-five drugs/targets in oncology and related fields. Recent collaborations include work on peptides for endometriosis/coronavirus with ValiRx plc and inflammatory disease with Numab Therapeutics AG.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Physiomics.